Jean Davignon
Affiliations: | McGill University, Montreal, QC, Canada |
Area:
BiochemistryGoogle:
"Jean Davignon"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wassef H, Bissonnette S, Dufour R, et al. (2017) Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women. The Journal of Nutrition |
| Genest J, Hegele RA, et al. (2014) Canadian Cardiovascular Society position statement on familial hypercholesterolemia. The Canadian Journal of Cardiology. 30: 1471-81 |
| Saavedra YG, Dufour R, Davignon J, et al. (2014) PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 2700-5 |
| Duell PB, Dubuc G, Seidah NG, et al. (2014) Clearance of plasma proprotein convertase subtilisin/kexin 9 by low-density lipoprotein apheresis. Circulation Research. 115: e3-4 |
| Awan Z, Dubuc G, Faraj M, et al. (2014) The effect of insulin on circulating PCSK9 in postmenopausal obese women. Clinical Biochemistry. 47: 1033-9 |
| Hermans MP, Fruchart J, Davignon J, et al. (2014) Residual Microvascular Risk in Type 2 Diabetes in 2014: Is it Time for a Re-Think? A Perspective from the Residual Risk Reduction Initiative (R3i) Journal of Diabetes & Metabolism. 5: 1-9 |
| Chen M, Davignon J, Baass A. (2014) Effects of Apolipoprotein E Polymorphism on Plasma Lipoprotein (a) Levels and Cardiovascular Outcomes in Familial Hypercholesterolemia Journal of Clinical Lipidology. 8: 304 |
| Sampalis T, Pesant Y, Elliott T, et al. (2014) Colt, multicenter capre open label randomized dose-ranging phase II trial to assess efficacy/safety in patients with mild-to-high hypertriglyceridemia Atherosclerosis. 235 |
| Awan Z, Delvin EE, Levy E, et al. (2013) Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotype. The Canadian Journal of Cardiology. 29: 927-33 |
| Mayne J, Ooi TC, Raymond A, et al. (2013) Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations. Lipids in Health and Disease. 12: 70 |